S. Tsiftsoglou

发表

Structures of the rat complement regulator CrrY

P. Roversi, Robert B Sim, Steven Johnson, 2011, Acta crystallographica. Section F, Structural biology and crystallization communications.

Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection

D. Zafeiriou, E. Roilides, A. Tragiannidis, 2022, Current issues in molecular biology.

T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS

I. Chiu, M. Carroll, T. Vartanian, 2008, Proceedings of the National Academy of Sciences.

Structural basis for complement factor I control and its disease-associated sequence polymorphisms

P. Roversi, Robert B Sim, Steven Johnson, 2011, Proceedings of the National Academy of Sciences.

SubstratesCofactors for Cleavage of Synthetic Human Complement Factor I Does Not

Stefanos A. Tsiftsoglou, Robert B. Sim, Robert B Sim, 2013 .

Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic Substrates 1

Robert B Sim, S. Tsiftsoglou, 2004, The Journal of Immunology.

SubstratesRequire Cofactors for Cleavage of Synthetic Human Complement Factor I Does Not

S. Tsiftsoglou, 2004 .

Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection

A. Anagnostopoulos, I. Sakellari, E. Gavriilaki, 2023, Immunobiology.

Identification of a dynamic gene regulatory network required for pluripotency factor‐induced reprogramming of mouse fibroblasts and hepatocytes

I. Talianidis, D. Thanos, P. Karagianni, 2020, The EMBO journal.

Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.

A. Tsiftsoglou, S. Tsiftsoglou, I. Bonovolias, 2009, Pharmacology & therapeutics.

Hemin accumulation and identification of a heme‐binding protein clan in K562 cells by proteomic and computational analysis

G. Panayotou, A. Tsiftsoglou, M. Samiotaki, 2021, Journal of cellular physiology.

Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.

C. Wagner, E. Sim, A. Kawamura, 2005, Biochemical pharmacology.

SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection

S. Tsiftsoglou, 2021, Molecular Immunology.

Complement C4 maintains peripheral B‐cell tolerance in a myeloid cell dependent manner

S. Degn, M. Carroll, S. A. Jones, 2013, European journal of immunology.

Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated Pathologies

S. Tsiftsoglou, 2023, Current issues in molecular biology.

Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides.

R. Dwek, P. Roversi, Robert B Sim, 2006, Biochimica et biophysica acta.

Proteases of the complement system.

R B Sim, Robert B Sim, S A Tsiftsoglou, 2004, Biochemical Society transactions.

The catalytically active serine protease domain of human complement factor I.

Robert B Sim, Xuehui Chen, Z. Rao, 2005, Biochemistry.

Complement C4 maintains peripheral B‐cell tolerance in a myeloid cell dependent manner

S. Degn, S. A. Jones, M. Alimzhanov, 2013, European journal of immunology.

Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K-562 and colorectal HCT-116 cancer cells

Androulla N. Miliotou, A. Tsiftsoglou, I. Vizirianakis, 2024, International journal of oncology.